Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 1151 to 1200 of 2027

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Glecaprevir–pibrentasvir for treating chronic hepatitis CTA499
Age-related macular degenerationNG82
Golimumab for treating active non-radiographic axial spondyloarthritisTA497
Autism spectrum disorder in under 19s: recognition, referral and diagnosisCG128
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA495
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA496
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failureHTG459
Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac deathHTG460
Endobronchial valve insertion to reduce lung volume in emphysemaHTG457
Transcutaneous microwave ablation for severe primary axillary hyperhidrosisHTG458
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system)HTG353
Transvaginal mesh repair of anterior or posterior vaginal wall prolapseHTG456
Naltrexone–bupropion for managing overweight and obesityTA494
Vismodegib for treating basal cell carcinomaTA489
Processed nerve allografts to repair peripheral nerve discontinuitiesHTG454
Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoeaHTG455
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxaneTA458
Tests in secondary care to identify people at high risk of ovarian cancerHTG453
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumoursTA488
Total distal radioulnar joint replacement for symptomatic joint instability or arthritisHTG451
Extracranial to intracranial bypass for intracranial atherosclerosisHTG452
Aflibercept for treating choroidal neovascularisationTA486
Sarilumab for moderate to severe rheumatoid arthritisTA485
Sinusitis (acute): antimicrobial prescribingNG79
Cataracts in adults: managementNG77
Cystic fibrosis: diagnosis and managementNG78
Hepatitis B (chronic): diagnosis and managementCG165
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Immunosuppressive therapy for kidney transplant in adultsTA481
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Child abuse and neglectNG76
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Reslizumab for treating severe eosinophilic asthmaTA479
Faltering growth: recognition and management of faltering growth in childrenNG75
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseHTG450
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Intermediate care including reablementNG74
Type 2 diabetes: prevention in people at high riskPH38
High-intensity focused ultrasound for symptomatic breast fibroadenomaHTG449
Ab externo canaloplasty for primary open-angle glaucomaHTG448
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Fertility problems: assessment and treatmentCG156
Sorafenib for treating advanced hepatocellular carcinomaTA474
Dimethyl fumarate for treating moderate to severe plaque psoriasisTA475
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancerTA476
Psoriasis: assessment and managementCG153
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neckTA473

Results per page

  1. 10
  2. 25
  3. 50
  4. All